NCT03587558 - Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract | Biotech Hunter

Enrollment

104

Participants

Timeline

Start Date

September 5, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2020

Conditions

Ventricular Premature ComplexesOutflow TractCarvedilol

Interventions

DRUG

Carvedilol

Patients in this group are taking carvedilol to inhibit outflow tract PVC/VT.

DRUG

Flecainide

Patients in this group are taking flecainide to inhibit outflow tract PVC/VT.

Trial Locations (11)

41931

RECRUITING

Keimyung University Dongsan Medical Center, Daegu

41944

RECRUITING

Division of Cardiology, Department of Internal Medicine, Kyungpook National University Hospital, Daegu

42415

RECRUITING

Division of Cardiology, Department of Internal Medicine, Yeungnam University Hospital, Daegu

42472

RECRUITING

Division of Cardiology, Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu

61469

RECRUITING

Chonnam National University Hospital, Gwangju

02841

RECRUITING

Korea University Anam Hospital, Seoul

03080

RECRUITING

Seoul National University Hospital, Seoul

03722

RECRUITING

Severance Cardiovascular Hospital, Seoul

05505

RECRUITING

Seoul Asan Medical Center, Seoul

06351

RECRUITING

Seoul Samsung Medical Center, Seoul

06591

RECRUITING

Seoul St. Mary's Hospital, Seoul